ALEXIS KIRK: Open Payments
NPI 1548933096 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$934 in 44 payments from 20 companies in 2025. Trend: 2023 $406 · 2024 $923 · 2025 $934
Food & beverage: $934
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $241 |
| ABBVIE INC. | 5 | $103 |
| PFIZER INC. | 5 | $94 |
| Lilly USA, LLC | 4 | $78 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Amgen Inc. | 2 | $29 |
| Ardelyx, Inc. | 1 | $29 |
Products named: Ozempic, Wegovy, TRELEGY ELLIPTA, JARDIANCE, VRAYLAR, ELIQUIS, MOUNJARO, XIFAXAN.
Industry payments across KY — which companies pay providers there.
